Abstract
Soluble epoxide hydrolase (sEH) is a novel target for the treatment of hypertension and vascular inflammation. A new class of potent non-urea sEH inhibitors was identified via high throughput screening (HTS) and chemical modification. IC50s of the most potent compounds range from micromolar to low nanomolar.
Original language | English (US) |
---|---|
Pages (from-to) | 2354-2359 |
Number of pages | 6 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 19 |
Issue number | 8 |
DOIs | |
State | Published - Apr 15 2009 |
Externally published | Yes |
Keywords
- HTS
- Nanomolar
- Non-urea
- sEH
ASJC Scopus subject areas
- Biochemistry
- Molecular Medicine
- Molecular Biology
- Pharmaceutical Science
- Drug Discovery
- Clinical Biochemistry
- Organic Chemistry